CIN Newsroom

Cannabis Investor News
  • 0.0 (0)
  • Investing

The daily audio brief for institutional cannabis investors. Trulieve moves, MSO earnings, distressed issuers, and the numbers behind the news. Five minutes, weekdays.

  1. 5d ago

    Five Before the Bell — The Week Ahead: August 16, 2026

    The single biggest question heading into the week: will the DEA rescheduling process—post-hearing briefs due August 17—produce enough regulatory clarity to move cannabis equities out of their current rangebound pattern? Read the full US brief for 2026-08-16.

  2. 5d ago

    Five Before the Bell — The Week Ahead: August 16, 2026

    What’s the market pricing for a regulatory win — or a regulatory delay — after the DEA rescheduling hearing wraps up this week? Read the full US brief for 2026-08-16.

  3. 5d ago

    Five Before the Bell — The Week Ahead: August 16, 2026

    The single biggest question heading into the week: will the DEA post-hearing schedule around August 17 trigger durable flows into U.S.-facing names, or will macro and narrow breadth keep cannabis equities rangebound? Read the full US brief for 2026-08-16.

  4. 5d ago

    Five Before the Bell — The Week Ahead: August 16, 2026

    The single biggest question hanging over cannabis equities this week is whether the DEA rescheduling record will produce a concrete policy signal by way of post‑hearing filings and industry reaction, or whether markets will remain rangebound into late summer. Read the full US brief for 2026-08-16.

  5. 5d ago

    Five Before the Bell — The Week Ahead: August 16, 2026

    The single biggest question heading into the week is whether the DEA rescheduling record will meaningfully shift capital flows into U.S.-exposed names ahead of post-hearing briefs due Monday, August 17. Read the full US brief for 2026-08-16.

  6. 5d ago

    Five Before the Bell — The Week Ahead: August 16, 2026

    The biggest question for cannabis equities heading into the week: will the DEA rescheduling docket — and the post-hearing filings due next week — create a concrete policy catalyst or just another headline that leaves the group rangebound? Read the full US brief for 2026-08-16.

  7. 5d ago

    Five Before the Bell — The Week Ahead: August 16, 2026

    The single biggest question hanging over cannabis equities this week is whether the DEA rescheduling record — with post-hearing briefs due Aug. 17 — produces any actionable signal about timing for a final administrative decision. Read the full US brief for 2026-08-16.

  8. 5d ago

    Five Before the Bell — The Week Ahead: August 16, 2026

    The single biggest question for cannabis equities this week: will the DEA rescheduling record — and its immediate post-hearing filings due August 17 — create a near-term directional catalyst, or will the market treat the submissions as noise and stay rangebound? Read the full US brief for 2026-08-16.

See All (55)

About

The daily audio brief for institutional cannabis investors. Trulieve moves, MSO earnings, distressed issuers, and the numbers behind the news. Five minutes, weekdays.

Information

  • Creator
    Cannabis Investor News
  • Years Active
    2026
  • Episodes
    55
  • Rating
    Clean
  • Copyright
    © 2026 Cannabis Investor News
  • Show Website
    CIN Newsroom